Then, performed independent validation on samples from the Australian Breast Cancer Tissue bank (ABCTB, n = 2351) achieving the following areas under the curve: 0.89 (ER), 0.81 (PR), and 0.79 (Her2). This evidence concerns the gene ERBB2 and breast carcinoma.